We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Russia’s Ministry of Health granted conditional approval for the vaccine last month, making it the first COVID-19 vaccine approved in the world. Read More
The FDA’s Aug. 23 Emergency Use Authorization (EUA) for convalescent plasma to treat COVID-19 has left hospitals with a choice — give the treatment to individual patients under the EUA or enroll them in clinical trials that will help settle the question of the treatment’s safety and efficacy. Read More
Researchers from Moscow’s Gamaleya Research Institute have posted results from two phase 1/2 trials of their controversial COVID-19 vaccine, showing it was safe and induced the production of antibodies in all adult volunteers. Read More
The U.S. may be gearing up for vaccine distribution, but a World Health Organization (WHO) spokesperson said Friday that the international agency doesn’t expect to see widespread vaccination with a COVID-19 vaccine until the middle of next year, stressing that more time is needed for late-stage clinical trials. Read More
Yeliva is currently in mid-to-late stage testing globally for hospitalized patients with severe COVID-19 pneumonia who require supplemental oxygen. Read More
RedHill Biopharma has announced positive steps in two late-stage trials evaluating its Yeliva (opaganib) for severe COVID-19 patients and said it plans to file an Emergency Use Authorization (EUA) for the drug as early as the end of the year. Read More
An independent Safety Monitoring committee has recommended the continuation of a phase 2 trial in the U.S., studying the drug in 40 severe COVID-19 patients. Read More